WIGGANS THOMAS G
Insider CIK 1208907 · ONXX Director · CBAY Director · SOMX Director · PCRX Director · ANNX Director · FMTX Director · DERM CEO & Chairman of the Board, Director · JSPR Director · PRDS Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 32,675 | — | $0 | 32,675 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy deriv | 2025-09-22 | 2025-09-24 | 41,000 | — | $0 | 41,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2025-09-22 | 2025-09-24 | 41,000 | $2.43 | $99.6K | 41,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-07-03 | 2025-07-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 80,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2023-11-28 | 2023-11-30 | 10,000 | $0.65 | $6.5K | 50,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2023-11-21 | 2023-11-22 | 10,000 | $0.64 | $6.4K | 40,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2023-11-20 | 2023-11-20 | 10,000 | $0.63 | $6.3K | 30,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2023-11-17 | 2023-11-20 | 10,000 | $0.60 | $6.0K | 20,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2023-11-16 | 2023-11-20 | 10,000 | $0.60 | $6.0K | 10,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-11-01 | 2023-11-02 | 110,000 | — | $0 | 110,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 985,000 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 450,000 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 562,500 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | U Tender | 2023-08-31 | 2023-08-31 | 50,000 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2023-02-01 | 2023-02-03 | 562,500 | — | $0 | 562,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2022-12-05 | 2022-12-07 | 12,500 | $1.09 | $13.6K | 50,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2022-12-02 | 2022-12-05 | 12,500 | $1.07 | $13.4K | 37,500 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2022-12-01 | 2022-12-05 | 25,000 | $1.04 | $26.0K | 25,000 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 25,000 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2022-09-14 | 2022-09-16 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 7,250 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2022-03-02 | 2022-03-04 | 985,000 | — | $0 | 985,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 67,000 | — | $0 | 67,000 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 2,750 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-04-05 | 2021-04-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2020-09-07 | 2020-09-09 | 25,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 150,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 180,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 180,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 355,170 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 98,430 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 64,327 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 300,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 9,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 15,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 50,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 115,022 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 164,642 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer | 2020-02-20 | 2020-02-24 | 180,985 | $18.75 | $3.39M | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer | 2020-02-20 | 2020-02-24 | 49,963 | $18.75 | $936.8K | 0 | SEC↗ |
| DERM Dermira, Inc. | G Gift | 2020-02-05 | 2020-02-24 | 27,000 | — | $0 | 49,963 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2019-08-19 | 2019-08-19 | 23,419 | $8.54 | $200.0K | 75,940 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-19 | 9,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-19 | 7,500 | — | $0 | 15,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-08-15 | 2019-08-19 | 9,000 | — | $0 | 48,666 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-08-15 | 2019-08-19 | 7,500 | — | $0 | 65,166 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-08-15 | 2019-08-19 | 9,000 | — | $0 | 57,666 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-08-15 | 2019-08-19 | 3,719 | $7.91 | $29.4K | 52,521 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-08-15 | 2019-08-19 | 4,463 | $7.91 | $35.3K | 56,240 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-08-15 | 2019-08-19 | 4,463 | $7.91 | $35.3K | 60,703 | SEC↗ |
| DERM Dermira, Inc. | G Gift | 2019-06-19 | 2019-08-19 | 5,000 | — | $0 | 39,666 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-02-12 | 2019-02-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-02-12 | 2019-02-14 | 300,000 | — | $0 | 300,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-08-15 | 2018-08-17 | 9,000 | — | $0 | 18,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-08-15 | 2018-08-17 | 2,500 | — | $0 | 22,500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-08-15 | 2018-08-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2018-08-15 | 2018-08-17 | 3,113 | $9.58 | $29.8K | 96,032 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2018-08-15 | 2018-08-17 | 3,113 | $9.58 | $29.8K | 92,919 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-08-15 | 2018-08-17 | 2,500 | — | $0 | 82,010 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2018-08-15 | 2018-08-17 | 865 | $9.58 | $8.3K | 99,145 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-08-15 | 2018-08-17 | 9,000 | — | $0 | 91,010 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-08-15 | 2018-08-17 | 9,000 | — | $0 | 100,010 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2018-07-09 | 2018-07-09 | 12,000 | $10.00 | $120.0K | 79,510 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 13,780 | $8.71 | $120.0K | 67,510 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2018-06-25 | 2018-06-25 | 12,150 | $9.84 | $119.6K | 53,730 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2018-06-18 | 2018-06-18 | 11,875 | $10.10 | $119.9K | 41,580 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-05-15 | 2018-05-16 | 10,000 | — | $0 | 164,642 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-05-15 | 2018-05-16 | 10,000 | $0.99 | $9.9K | 29,705 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 150,000 | $28.25 | $4.24M | 150,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-12-21 | 2017-12-22 | 5,000 | — | $0 | 115,022 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-12-21 | 2017-12-22 | 5,000 | $1.22 | $6.1K | 18,662 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-12-13 | 2017-12-15 | 5,000 | — | $0 | 174,642 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-12-13 | 2017-12-15 | 5,000 | $27.51 | $137.6K | 13,662 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-12-13 | 2017-12-15 | 5,000 | $0.99 | $5.0K | 18,662 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-11-02 | 2017-11-03 | 5,000 | — | $0 | 179,642 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-11-02 | 2017-11-03 | 5,000 | $27.52 | $137.6K | 13,427 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-11-02 | 2017-11-03 | 5,000 | $0.99 | $5.0K | 18,427 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-10-10 | 2017-10-11 | 5,000 | — | $0 | 184,642 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-10-10 | 2017-10-11 | 5,000 | $27.52 | $137.6K | 13,427 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-10-10 | 2017-10-11 | 5,000 | $0.99 | $5.0K | 18,427 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-09-18 | 2017-09-19 | 9,500 | — | $0 | 189,642 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-09-18 | 2017-09-19 | 9,500 | $27.51 | $261.3K | 13,427 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-09-18 | 2017-09-19 | 9,500 | $0.99 | $9.4K | 22,927 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-08-15 | 2017-08-17 | 3,000 | — | $0 | 27,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-08-15 | 2017-08-17 | 9,000 | — | $0 | 18,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-08-15 | 2017-08-17 | 3,000 | — | $0 | 19,690 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2017-08-15 | 2017-08-17 | 1,566 | $23.58 | $36.9K | 18,124 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2017-08-15 | 2017-08-17 | 4,697 | $23.58 | $110.8K | 13,427 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-08-15 | 2017-08-17 | 9,000 | — | $0 | 16,690 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-08-01 | 2017-08-02 | 500 | — | $0 | 199,142 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-08-01 | 2017-08-02 | 500 | $27.58 | $13.8K | 7,690 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-08-01 | 2017-08-02 | 500 | $0.99 | $495 | 8,190 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-07-03 | 2017-07-05 | 5,000 | — | $0 | 199,642 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-07-03 | 2017-07-05 | 5,000 | $0.99 | $5.0K | 12,690 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-07-03 | 2017-07-05 | 5,000 | $29.06 | $145.3K | 7,690 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-06-02 | 2017-06-05 | 1,121 | — | $0 | 204,642 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-06-02 | 2017-06-05 | 1,121 | $0.99 | $1.1K | 8,811 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-06-02 | 2017-06-05 | 1,121 | $27.61 | $31.0K | 7,690 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-06-01 | 2017-06-05 | 3,879 | — | $0 | 205,763 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-06-01 | 2017-06-05 | 3,879 | $27.50 | $106.7K | 7,690 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-06-01 | 2017-06-05 | 3,879 | $0.99 | $3.8K | 11,569 | SEC↗ |
| DERM Dermira, Inc. | G Gift | 2017-05-12 | 2017-06-05 | 1,000 | — | $0 | 131,180 | SEC↗ |
| DERM Dermira, Inc. | G Gift | 2017-05-12 | 2017-06-05 | 2,000 | — | $0 | 132,180 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-05-01 | 2017-05-03 | 8,000 | — | $0 | 209,642 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-05-01 | 2017-05-03 | 8,000 | $0.99 | $7.9K | 14,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-05-01 | 2017-05-03 | 100 | $34.39 | $3.4K | 6,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-05-01 | 2017-05-03 | 7,900 | $33.65 | $265.8K | 6,568 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-04-03 | 2017-04-04 | 8,000 | — | $0 | 217,642 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-04-03 | 2017-04-04 | 1,414 | $34.03 | $48.1K | 6,468 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-04-03 | 2017-04-04 | 8,000 | $0.99 | $7.9K | 14,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-04-03 | 2017-04-04 | 6,586 | $33.38 | $219.8K | 7,882 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-03-03 | 2017-03-07 | 4,000 | — | $0 | 225,642 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-03-03 | 2017-03-07 | 4,000 | $0.99 | $4.0K | 10,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-03-03 | 2017-03-07 | 4,000 | $37.60 | $150.4K | 6,468 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-03-01 | 2017-03-02 | 11,000 | — | $0 | 229,642 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 600 | $35.08 | $21.0K | 6,740 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 4,328 | $33.91 | $146.8K | 7,340 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 5,800 | $32.99 | $191.3K | 11,668 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-03-01 | 2017-03-02 | 11,000 | $0.99 | $10.9K | 17,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 272 | $35.91 | $9.8K | 6,468 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-02-17 | 2017-02-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-02-17 | 2017-02-22 | 180,000 | $33.84 | $6.09M | 180,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-02-01 | 2017-02-03 | 5,000 | — | $0 | 240,642 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-02-01 | 2017-02-03 | 4,796 | $29.33 | $140.7K | 6,672 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-02-01 | 2017-02-03 | 204 | $29.99 | $6.1K | 6,468 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-02-01 | 2017-02-03 | 5,000 | $0.99 | $5.0K | 11,468 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-01-04 | 2017-01-05 | 3,000 | — | $0 | 245,642 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-01-04 | 2017-01-05 | 3,000 | $0.99 | $3.0K | 9,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-01-04 | 2017-01-05 | 3,000 | $32.51 | $97.5K | 6,468 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 5,000 | — | $0 | 248,642 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 5,000 | $0.99 | $5.0K | 11,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-01-03 | 2017-01-05 | 5,000 | $30.19 | $150.9K | 6,468 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-12-01 | 2016-12-02 | 2,881 | $31.53 | $90.8K | 134,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-12-01 | 2016-12-02 | 8,119 | $30.54 | $248.0K | 137,061 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-11-01 | 2016-11-02 | 11,000 | $31.19 | $343.1K | 145,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-10-03 | 2016-10-04 | 8,900 | $34.54 | $307.4K | 158,280 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-10-03 | 2016-10-04 | 2,100 | $34.86 | $73.2K | 156,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-09-01 | 2016-09-02 | 9,700 | $31.73 | $307.8K | 168,480 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-09-01 | 2016-09-02 | 1,300 | $30.88 | $40.1K | 167,180 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-08-15 | 2016-08-16 | 3,000 | — | $0 | 27,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-08-15 | 2016-08-16 | 3,000 | — | $0 | 6,512 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2016-08-15 | 2016-08-16 | 1,128 | $31.59 | $35.6K | 5,384 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-08-01 | 2016-08-03 | 300 | $32.62 | $9.8K | 182,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-08-01 | 2016-08-03 | 10,700 | $33.21 | $355.3K | 182,480 | SEC↗ |
| DERM Dermira, Inc. | G Gift | 2016-07-26 | 2016-08-03 | 2,000 | — | $0 | 180,180 | SEC↗ |
| DERM Dermira, Inc. | G Gift | 2016-07-26 | 2016-08-03 | 2,000 | — | $0 | 178,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-07-05 | 2016-07-06 | 2,000 | $30.18 | $60.4K | 193,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-07-01 | 2016-07-06 | 9,000 | $29.49 | $265.4K | 195,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-06-01 | 2016-06-03 | 10,153 | $31.61 | $320.9K | 205,027 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-06-01 | 2016-06-03 | 847 | $31.08 | $26.3K | 204,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-05-02 | 2016-05-03 | 9,000 | $25.11 | $226.0K | 215,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-04-01 | 2016-04-05 | 7,000 | $20.69 | $144.8K | 224,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-03-01 | 2016-03-02 | 7,000 | $22.57 | $158.0K | 231,180 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2016-02-05 | 2016-02-09 | 180,000 | — | $0 | 180,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2016-02-05 | 2016-02-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-02-01 | 2016-02-03 | 300 | $27.89 | $8.4K | 238,180 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-02-01 | 2016-02-03 | 8,700 | $27.23 | $236.9K | 238,480 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-01-04 | 2016-01-06 | 10,492 | $33.13 | $347.6K | 247,688 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-01-04 | 2016-01-06 | 508 | $33.95 | $17.2K | 247,180 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 82,043 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 25,965 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion | 2014-10-08 | 2014-10-08 | 108,008 | — | $0 | 263,180 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2014-10-02 | 2014-10-02 | 355,170 | — | $0 | 355,170 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 2,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 6,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 10,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 10,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,287 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,900 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | U Tender | 2013-10-01 | 2013-10-03 | 6,015 | $125.00 | $751.9K | 2,100 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2013-10-01 | 2013-10-03 | 2,100 | $125.00 | $262.5K | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | G Gift | 2013-05-21 | 2013-05-23 | 850 | — | $0 | 8,115 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-05-06 | 2013-05-08 | 2,000 | — | $0 | 6,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-05-06 | 2013-05-08 | 2,500 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-05-06 | 2013-05-08 | 2,000 | $27.63 | $55.3K | 13,465 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-05-06 | 2013-05-08 | 4,500 | $91.01 | $409.5K | 8,965 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-05-06 | 2013-05-08 | 2,500 | $25.30 | $63.3K | 11,465 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-05 | 2013-04-09 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-04-05 | 2013-04-09 | 2,500 | $25.30 | $63.3K | 12,665 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-05 | 2013-04-09 | 1,200 | $86.00 | $103.2K | 8,965 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-05 | 2013-04-09 | 2,500 | $86.00 | $215.0K | 10,165 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2013-03-28 | 2013-04-01 | 5,900 | — | $0 | 5,900 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2013-03-28 | 2013-04-01 | 2,100 | — | $0 | 10,165 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-03-08 | 2013-03-11 | 2,000 | — | $0 | 8,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-03-08 | 2013-03-11 | 2,000 | $85.00 | $170.0K | 8,065 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-03-08 | 2013-03-11 | 2,000 | $27.63 | $55.3K | 10,065 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-03-05 | 2013-03-05 | 2,500 | — | $0 | 5,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-03-05 | 2013-03-05 | 2,500 | $77.20 | $193.0K | 8,065 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-03-05 | 2013-03-05 | 2,500 | $25.30 | $63.3K | 10,565 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-02-05 | 2013-02-06 | 2,500 | — | $0 | 7,500 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-02-05 | 2013-02-06 | 2,500 | $25.30 | $63.3K | 10,565 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-02-05 | 2013-02-06 | 2,500 | $77.29 | $193.2K | 8,065 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2012-08-16 | 2012-08-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-16 | 2012-08-17 | 2,000 | $68.60 | $137.2K | 8,065 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-16 | 2012-08-17 | 10,000 | $68.63 | $686.3K | 10,065 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-08-16 | 2012-08-17 | 10,000 | $25.30 | $253.0K | 20,065 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2012-07-25 | 2012-07-27 | 2,000 | — | $0 | 2,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-07-25 | 2012-07-27 | 1,500 | — | $0 | 10,065 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 33,453 | — | $0 | 122,287 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | G Gift | 2012-05-17 | 2012-05-18 | 1,750 | — | $0 | 8,565 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-04-02 | 2012-04-04 | 62,308 | — | $0 | 88,834 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2012-03-30 | 2012-04-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 3,000 | — | $0 | 10,315 | SEC↗ |